Cable Hill Partners, LLC Intercept Pharmaceuticals, Inc. Transaction History

Cable Hill Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$77.77 - $120.68 $777 - $1,206	-10 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$91.83 - $120.68 $1,101 - $1,448	-12 Reduced 54.55%	10 $1,000
Q4 2018 Feb 12, 2019	BUY	$85.79 - $126.46 $1,887 - $2,782	22 New	22 $2,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.